A detailed history of Northern Trust Corp transactions in Harmony Biosciences Holdings, Inc. stock. As of the latest transaction made, Northern Trust Corp holds 294,117 shares of HRMY stock, worth $9.77 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
294,117
Previous 307,268 4.28%
Holding current value
$9.77 Million
Previous $9.27 Million 26.74%
% of portfolio
0.0%
Previous 0.0%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$30.0 - $39.95 $394,530 - $525,382
-13,151 Reduced 4.28%
294,117 $11.7 Million
Q2 2024

Aug 14, 2024

SELL
$28.81 - $33.01 $468,047 - $536,280
-16,246 Reduced 5.02%
307,268 $9.27 Million
Q1 2024

May 14, 2024

SELL
$29.93 - $35.06 $239,499 - $280,550
-8,002 Reduced 2.41%
323,514 $10.9 Million
Q4 2023

Feb 13, 2024

SELL
$19.2 - $33.78 $245,664 - $432,215
-12,795 Reduced 3.72%
331,516 $10.7 Million
Q3 2023

Nov 13, 2023

BUY
$31.89 - $39.03 $383,541 - $469,413
12,027 Added 3.62%
344,311 $11.3 Million
Q2 2023

Aug 11, 2023

BUY
$30.5 - $37.4 $1.77 Million - $2.17 Million
58,018 Added 21.15%
332,284 $11.7 Million
Q1 2023

May 15, 2023

SELL
$30.8 - $53.92 $18,110 - $31,704
-588 Reduced 0.21%
274,266 $8.95 Million
Q4 2022

Feb 13, 2023

BUY
$45.4 - $60.91 $264,999 - $355,531
5,837 Added 2.17%
274,854 $15.1 Million
Q3 2022

Nov 14, 2022

BUY
$42.06 - $55.45 $609,323 - $803,304
14,487 Added 5.69%
269,017 $11.9 Million
Q2 2022

Aug 12, 2022

BUY
$33.54 - $52.15 $717,621 - $1.12 Million
21,396 Added 9.18%
254,530 $12.4 Million
Q1 2022

May 13, 2022

SELL
$33.14 - $51.13 $254,846 - $393,189
-7,690 Reduced 3.19%
233,134 $11.3 Million
Q4 2021

Feb 08, 2022

BUY
$34.09 - $43.91 $972,110 - $1.25 Million
28,516 Added 13.43%
240,824 $10.3 Million
Q3 2021

Nov 15, 2021

BUY
$25.68 - $38.61 $569,762 - $856,640
22,187 Added 11.67%
212,308 $8.14 Million
Q2 2021

Aug 13, 2021

BUY
$25.96 - $33.44 $3.15 Million - $4.06 Million
121,335 Added 176.39%
190,121 $5.37 Million
Q1 2021

May 12, 2021

SELL
$27.56 - $40.37 $149,568 - $219,087
-5,427 Reduced 7.31%
68,786 $2.27 Million
Q4 2020

Feb 11, 2021

BUY
$31.74 - $51.34 $2.36 Million - $3.81 Million
74,213 New
74,213 $2.68 Million

Others Institutions Holding HRMY

About Harmony Biosciences Holdings, Inc.


  • Ticker HRMY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,161,400
  • Market Cap $1.97B
  • Description
  • Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, develops and commercializes therapies for patients with rare neurological disorders in the United States. Its product, WAKIX is a medication for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. The company was formerly known as Harmony ...
More about HRMY
Track This Portfolio

Track Northern Trust Corp Portfolio

Follow Northern Trust Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

News

Stay updated on Northern Trust Corp with notifications on news.